ID   MCE1_HUMAN              Reviewed;         597 AA.
AC   O60942; E1P513; E1P514; O43483; O60257; O60351; Q5TCW8; Q8WUM8;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   28-JUN-2023, entry version 206.
DE   RecName: Full=mRNA-capping enzyme;
DE   AltName: Full=HCAP1;
DE   AltName: Full=HCE;
DE   Includes:
DE     RecName: Full=mRNA 5'-triphosphate monophosphatase;
DE              EC=3.6.1.74 {ECO:0000269|PubMed:9473487};
DE     AltName: Full=mRNA 5'-phosphatase;
DE   Includes:
DE     RecName: Full=mRNA guanylyltransferase;
DE              EC=2.7.7.50 {ECO:0000269|PubMed:9473487};
DE     AltName: Full=GTP--RNA guanylyltransferase;
DE              Short=GTase;
GN   Name=RNGTT; Synonyms=CAP1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9371772; DOI=10.1073/pnas.94.24.12898;
RA   Yue Z., Maldonado E., Pillutla R., Cho H., Reinberg D., Shatkin A.J.;
RT   "Mammalian capping enzyme complements mutant Saccharomyces cerevisiae
RT   lacking mRNA guanylyltransferase and selectively binds the elongating form
RT   of RNA polymerase II.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:12898-12903(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), MUTAGENESIS OF LYS-294;
RP   ARG-299; GLU-345; LYS-458 AND LYS-460, AND FUNCTION.
RX   PubMed=9512541; DOI=10.1093/nar/26.7.1700;
RA   Yamada-Okabe T., Doi R., Shimmi O., Arisawa M., Yamada-Okabe H.;
RT   "Isolation and characterization of a human cDNA for mRNA 5'-capping
RT   enzyme.";
RL   Nucleic Acids Res. 26:1700-1706(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=9473487; DOI=10.1006/bbrc.1997.8038;
RA   Tsukamoto T., Shibagaki Y., Murakoshi T., Suzuki M., Nakamura A., Gotoh H.,
RA   Mizumoto K.;
RT   "Cloning and characterization of two human cDNAs encoding the mRNA capping
RT   enzyme.";
RL   Biochem. Biophys. Res. Commun. 243:101-108(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-594.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH RNMT.
RX   PubMed=9705270; DOI=10.1074/jbc.273.34.21443;
RA   Pillutla R.C., Yue Z., Maldonado E., Shatkin A.J.;
RT   "Recombinant human mRNA cap methyltransferase binds capping enzyme/RNA
RT   polymerase IIo complexes.";
RL   J. Biol. Chem. 273:21443-21446(1998).
RN   [8]
RP   INTERACTION WITH SUPT5H.
RX   PubMed=10421630; DOI=10.1101/gad.13.14.1774;
RA   Wen Y., Shatkin A.J.;
RT   "Transcription elongation factor hSPT5 stimulates mRNA capping.";
RL   Genes Dev. 13:1774-1779(1999).
RN   [9]
RP   INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION).
RX   PubMed=11278368; DOI=10.1074/jbc.m007901200;
RA   Chiu Y.-L., Coronel E., Ho C.K., Shuman S., Rana T.M.;
RT   "HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates
RT   capping of TAR RNA.";
RL   J. Biol. Chem. 276:12959-12966(2001).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) OF 229-567, CATALYTIC ACTIVITY,
RP   FUNCTION, MUTAGENESIS OF GLU-234; LYS-458; LYS-460; ARG-528; ARG-530;
RP   ASP-532 AND LYS-533, AND ACTIVE SITE.
RX   PubMed=21636784; DOI=10.1073/pnas.1106610108;
RA   Chu C., Das K., Tyminski J.R., Bauman J.D., Guan R., Qiu W.,
RA   Montelione G.T., Arnold E., Shatkin A.J.;
RT   "Structure of the guanylyltransferase domain of human mRNA capping
RT   enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:10104-10108(2011).
CC   -!- FUNCTION: Bifunctional mRNA-capping enzyme exhibiting RNA 5'-
CC       triphosphate monophosphatase activity in the N-terminal part and mRNA
CC       guanylyltransferase activity in the C-terminal part. Catalyzes the
CC       first two steps of cap formation: by removing the gamma-phosphate from
CC       the 5'-triphosphate end of nascent mRNA to yield a diphosphate end, and
CC       by transferring the GMP moiety of GTP to the 5'-diphosphate terminus of
CC       RNA via a covalent enzyme-GMP reaction intermediate.
CC       {ECO:0000269|PubMed:21636784, ECO:0000269|PubMed:9473487,
CC       ECO:0000269|PubMed:9512541}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end triphospho-ribonucleoside in mRNA + H2O = a 5'-end
CC         diphospho-ribonucleoside in mRNA + H(+) + phosphate;
CC         Xref=Rhea:RHEA:67004, Rhea:RHEA-COMP:17164, Rhea:RHEA-COMP:17165,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:167616, ChEBI:CHEBI:167618; EC=3.6.1.74;
CC         Evidence={ECO:0000269|PubMed:9473487};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67005;
CC         Evidence={ECO:0000305|PubMed:9473487};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end diphospho-ribonucleoside in mRNA + GTP + H(+) = a 5'-
CC         end (5'-triphosphoguanosine)-(ribonucleoside) in mRNA + diphosphate;
CC         Xref=Rhea:RHEA:67012, Rhea:RHEA-COMP:17165, Rhea:RHEA-COMP:17166,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:167616, ChEBI:CHEBI:167617; EC=2.7.7.50;
CC         Evidence={ECO:0000269|PubMed:9473487};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67013;
CC         Evidence={ECO:0000305|PubMed:9473487};
CC   -!- SUBUNIT: Interacts with POLR2A (via C-terminus); this enhances
CC       guanylyltransferase activity. Binds (via GTase domain) to the
CC       elongating phosphorylated form of RNA polymerase II; can form direct
CC       interactions with the phosphorylated POLR2A C-terminal domain and
CC       indirect interactions via bound RNA (By similarity). Interacts with
CC       SUPT5H and RNMT. Interacts with HIV-1 Tat. {ECO:0000250,
CC       ECO:0000269|PubMed:10421630, ECO:0000269|PubMed:9705270}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HIV-1 Tat.
CC       {ECO:0000269|PubMed:11278368}.
CC   -!- INTERACTION:
CC       O60942; Q92624: APPBP2; NbExp=3; IntAct=EBI-1237132, EBI-743771;
CC       O60942; P16333-1: NCK1; NbExp=2; IntAct=EBI-1237132, EBI-15578122;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=HCE1, HCAP1A;
CC         IsoId=O60942-1; Sequence=Displayed;
CC       Name=2; Synonyms=HCE1A;
CC         IsoId=O60942-2; Sequence=VSP_003202;
CC       Name=3; Synonyms=HCE1B;
CC         IsoId=O60942-3; Sequence=VSP_003202, VSP_003203;
CC       Name=4; Synonyms=HCAP1B;
CC         IsoId=O60942-4; Sequence=VSP_003204;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 4 (at a lesser extent) are
CC       expressed in cerebrum, cerebellum, thyroid, lung, heart, liver, kidney,
CC       spleen, large intestine, testis, skin and muscle.
CC   -!- MISCELLANEOUS: Isoform 2 to isoform 4 lack mRNA 5'-guanylyltransferase
CC       activity due to disruptions of the GTase domain.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the non-receptor
CC       class of the protein-tyrosine phosphatase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the eukaryotic GTase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF025654; AAB91559.1; -; mRNA.
DR   EMBL; AB009022; BAA25894.1; -; mRNA.
DR   EMBL; AB009023; BAA25895.1; -; mRNA.
DR   EMBL; AB009024; BAA25896.1; -; mRNA.
DR   EMBL; AB012142; BAA25198.1; -; mRNA.
DR   EMBL; AB012143; BAA25199.1; -; mRNA.
DR   EMBL; AL079342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL096868; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133408; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL445530; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48566.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48567.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48569.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48570.1; -; Genomic_DNA.
DR   EMBL; BC019954; AAH19954.1; -; mRNA.
DR   CCDS; CCDS5017.1; -. [O60942-1]
DR   CCDS; CCDS69153.1; -. [O60942-2]
DR   PIR; JC5936; JC5936.
DR   PIR; JC5937; JC5937.
DR   RefSeq; NP_001273355.1; NM_001286426.1. [O60942-2]
DR   RefSeq; NP_001273357.1; NM_001286428.1.
DR   RefSeq; NP_003791.3; NM_003800.4. [O60942-1]
DR   PDB; 2C46; X-ray; 1.60 A; A/B/C/D=1-219.
DR   PDB; 3S24; X-ray; 3.01 A; A/B/C/D/E/F/G=229-567.
DR   PDBsum; 2C46; -.
DR   PDBsum; 3S24; -.
DR   AlphaFoldDB; O60942; -.
DR   SMR; O60942; -.
DR   BioGRID; 114270; 129.
DR   DIP; DIP-61014N; -.
DR   IntAct; O60942; 27.
DR   MINT; O60942; -.
DR   STRING; 9606.ENSP00000358497; -.
DR   DEPOD; RNGTT; -.
DR   GlyGen; O60942; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O60942; -.
DR   MetOSite; O60942; -.
DR   PhosphoSitePlus; O60942; -.
DR   BioMuta; RNGTT; -.
DR   EPD; O60942; -.
DR   jPOST; O60942; -.
DR   MassIVE; O60942; -.
DR   MaxQB; O60942; -.
DR   PaxDb; O60942; -.
DR   PeptideAtlas; O60942; -.
DR   ProteomicsDB; 49688; -. [O60942-1]
DR   ProteomicsDB; 49689; -. [O60942-2]
DR   ProteomicsDB; 49690; -. [O60942-3]
DR   ProteomicsDB; 49691; -. [O60942-4]
DR   Antibodypedia; 1158; 187 antibodies from 30 providers.
DR   DNASU; 8732; -.
DR   Ensembl; ENST00000369475.7; ENSP00000358487.4; ENSG00000111880.16. [O60942-2]
DR   Ensembl; ENST00000369485.9; ENSP00000358497.4; ENSG00000111880.16. [O60942-1]
DR   Ensembl; ENST00000538899.2; ENSP00000442609.2; ENSG00000111880.16. [O60942-3]
DR   GeneID; 8732; -.
DR   KEGG; hsa:8732; -.
DR   MANE-Select; ENST00000369485.9; ENSP00000358497.4; NM_003800.5; NP_003791.3.
DR   UCSC; uc003pmr.4; human. [O60942-1]
DR   AGR; HGNC:10073; -.
DR   CTD; 8732; -.
DR   DisGeNET; 8732; -.
DR   GeneCards; RNGTT; -.
DR   HGNC; HGNC:10073; RNGTT.
DR   HPA; ENSG00000111880; Low tissue specificity.
DR   MIM; 603512; gene.
DR   neXtProt; NX_O60942; -.
DR   OpenTargets; ENSG00000111880; -.
DR   PharmGKB; PA34446; -.
DR   VEuPathDB; HostDB:ENSG00000111880; -.
DR   eggNOG; KOG2386; Eukaryota.
DR   GeneTree; ENSGT00940000156953; -.
DR   HOGENOM; CLU_021710_3_0_1; -.
DR   InParanoid; O60942; -.
DR   OMA; FWDIWMS; -.
DR   OrthoDB; 49440at2759; -.
DR   PhylomeDB; O60942; -.
DR   TreeFam; TF314914; -.
DR   BioCyc; MetaCyc:HS03479-MON; -.
DR   BRENDA; 2.7.7.50; 2681.
DR   BRENDA; 3.6.1.74; 2681.
DR   PathwayCommons; O60942; -.
DR   Reactome; R-HSA-167160; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection.
DR   Reactome; R-HSA-72086; mRNA Capping.
DR   Reactome; R-HSA-77075; RNA Pol II CTD phosphorylation and interaction with CE.
DR   SignaLink; O60942; -.
DR   SIGNOR; O60942; -.
DR   BioGRID-ORCS; 8732; 835 hits in 1154 CRISPR screens.
DR   ChiTaRS; RNGTT; human.
DR   EvolutionaryTrace; O60942; -.
DR   GeneWiki; RNGTT; -.
DR   GenomeRNAi; 8732; -.
DR   Pharos; O60942; Tbio.
DR   PRO; PR:O60942; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; O60942; protein.
DR   Bgee; ENSG00000111880; Expressed in cardia of stomach and 201 other tissues.
DR   Genevisible; O60942; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0050355; F:inorganic triphosphate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0140818; F:mRNA 5'-phosphatase activity; IEA:InterPro.
DR   GO; GO:0004484; F:mRNA guanylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004651; F:polynucleotide 5'-phosphatase activity; TAS:Reactome.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0008192; F:RNA guanylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0006370; P:7-methylguanosine mRNA capping; IDA:UniProtKB.
DR   GO; GO:0006470; P:protein dephosphorylation; IEA:InterPro.
DR   GO; GO:0006396; P:RNA processing; IDA:UniProtKB.
DR   CDD; cd07895; Adenylation_mRNA_capping; 1.
DR   CDD; cd17664; Mce1_N; 1.
DR   Gene3D; 3.30.1490.430; -; 1.
DR   Gene3D; 3.30.470.30; DNA ligase/mRNA capping enzyme; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR017074; mRNA_cap_enz_bifunc.
DR   InterPro; IPR001339; mRNA_cap_enzyme_adenylation.
DR   InterPro; IPR013846; mRNA_cap_enzyme_C.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR10367; MRNA-CAPPING ENZYME; 1.
DR   PANTHER; PTHR10367:SF17; MRNA-CAPPING ENZYME; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   Pfam; PF03919; mRNA_cap_C; 1.
DR   Pfam; PF01331; mRNA_cap_enzyme; 1.
DR   PIRSF; PIRSF036958; mRNA_capping_HCE; 1.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   SUPFAM; SSF56091; DNA ligase/mRNA capping enzyme, catalytic domain; 1.
DR   SUPFAM; SSF50249; Nucleic acid-binding proteins; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; GTP-binding; Host-virus interaction;
KW   Hydrolase; mRNA capping; mRNA processing; Multifunctional enzyme;
KW   Nucleotide-binding; Nucleotidyltransferase; Nucleus; Protein phosphatase;
KW   Reference proteome; Transferase.
FT   CHAIN           1..597
FT                   /note="mRNA-capping enzyme"
FT                   /id="PRO_0000210108"
FT   DOMAIN          25..183
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          1..212
FT                   /note="TPase"
FT   REGION          181..220
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          229..597
FT                   /note="GTase"
FT   REGION          330..386
FT                   /note="Interaction with POLR2A"
FT                   /evidence="ECO:0000250"
FT   REGION          570..597
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        192..207
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        583..597
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        126
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        294
FT                   /note="N6-GMP-lysine intermediate"
FT                   /evidence="ECO:0000269|PubMed:21636784"
FT   BINDING         299
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         315
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   BINDING         343..345
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   BINDING         458..460
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   BINDING         528..533
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         424..446
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9512541"
FT                   /id="VSP_003202"
FT   VAR_SEQ         481..597
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9512541"
FT                   /id="VSP_003203"
FT   VAR_SEQ         504..597
FT                   /note="TKELKQYDNKIIECKFENNSWVFMRQRTDKSFPNAYNTAMAVCNSISNPVTK
FT                   EMLFEFIDRCTAASQGQKRKHHLDPDTELMPPPPPKRPRPLT -> CLFIFSVLFLDVL
FT                   LSGIHQNLANNNQHIKISCSSTLGG (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9473487"
FT                   /id="VSP_003204"
FT   VARIANT         594
FT                   /note="R -> H (in dbSNP:rs17856595)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_046481"
FT   MUTAGEN         234
FT                   /note="E->A: No effect on GTase activity."
FT                   /evidence="ECO:0000269|PubMed:21636784"
FT   MUTAGEN         294
FT                   /note="K->A: Loss of GTase activity."
FT                   /evidence="ECO:0000269|PubMed:9512541"
FT   MUTAGEN         299
FT                   /note="R->A: Loss of GTase activity."
FT                   /evidence="ECO:0000269|PubMed:9512541"
FT   MUTAGEN         345
FT                   /note="E->A: Loss of GTase activity."
FT                   /evidence="ECO:0000269|PubMed:9512541"
FT   MUTAGEN         458
FT                   /note="K->A: Loss of GTase activity."
FT                   /evidence="ECO:0000269|PubMed:21636784,
FT                   ECO:0000269|PubMed:9512541"
FT   MUTAGEN         460
FT                   /note="K->A: Loss of GTase activity."
FT                   /evidence="ECO:0000269|PubMed:21636784,
FT                   ECO:0000269|PubMed:9512541"
FT   MUTAGEN         528
FT                   /note="R->A: Strongly reduced GTase activity."
FT                   /evidence="ECO:0000269|PubMed:21636784"
FT   MUTAGEN         530
FT                   /note="R->A: Loss of GTase activity."
FT                   /evidence="ECO:0000269|PubMed:21636784"
FT   MUTAGEN         532
FT                   /note="D->A: Loss of GTase activity."
FT                   /evidence="ECO:0000269|PubMed:21636784"
FT   MUTAGEN         533
FT                   /note="K->A: Loss of GTase activity."
FT                   /evidence="ECO:0000269|PubMed:21636784"
FT   CONFLICT        30
FT                   /note="M -> I (in Ref. 1; AAB91559)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="P -> T (in Ref. 6; AAH19954)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        484
FT                   /note="Q -> P (in Ref. 1; AAB91559)"
FT                   /evidence="ECO:0000305"
FT   TURN            21..23
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   STRAND          24..27
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           33..38
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           41..43
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           47..57
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   STRAND          60..66
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           77..80
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   TURN            81..83
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   STRAND          85..88
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           100..110
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   STRAND          120..125
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   STRAND          127..130
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           131..143
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           149..159
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           167..177
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   HELIX           180..182
FT                   /evidence="ECO:0007829|PDB:2C46"
FT   STRAND          232..235
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          241..243
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           247..261
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          270..275
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   TURN            278..280
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           281..285
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          289..295
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          298..304
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          306..308
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          310..314
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          319..324
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          339..351
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          354..367
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           372..374
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           377..387
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           389..394
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   TURN            395..397
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          398..401
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   TURN            403..405
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          406..412
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           418..424
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          437..446
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          451..459
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           462..464
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          466..476
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          484..490
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          498..501
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           507..509
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          512..520
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   STRAND          523..529
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           539..550
FT                   /evidence="ECO:0007829|PDB:3S24"
FT   HELIX           555..563
FT                   /evidence="ECO:0007829|PDB:3S24"
SQ   SEQUENCE   597 AA;  68557 MW;  51CEEC1B190603DE CRC64;
     MAHNKIPPRW LNCPRRGQPV AGRFLPLKTM LGPRYDSQVA EENRFHPSML SNYLKSLKVK
     MGLLVDLTNT SRFYDRNDIE KEGIKYIKLQ CKGHGECPTT ENTETFIRLC ERFNERNPPE
     LIGVHCTHGF NRTGFLICAF LVEKMDWSIE AAVATFAQAR PPGIYKGDYL KELFRRYGDI
     EEAPPPPLLP DWCFEDDEDE DEDEDGKKES EPGSSASFGK RRKERLKLGA IFLEGVTVKG
     VTQVTTQPKL GEVQQKCHQF CGWEGSGFPG AQPVSMDKQN IKLLDLKPYK VSWKADGTRY
     MMLIDGTNEV FMIDRDNSVF HVSNLEFPFR KDLRMHLSNT LLDGEMIIDR VNGQAVPRYL
     IYDIIKFNSQ PVGDCDFNVR LQCIEREIIS PRHEKMKTGL IDKTQEPFSV RNKPFFDICT
     SRKLLEGNFA KEVSHEMDGL IFQPTGKYKP GRCDDILKWK PPSLNSVDFR LKITRMGGEG
     LLPQNVGLLY VGGYERPFAQ IKVTKELKQY DNKIIECKFE NNSWVFMRQR TDKSFPNAYN
     TAMAVCNSIS NPVTKEMLFE FIDRCTAASQ GQKRKHHLDP DTELMPPPPP KRPRPLT
//
